Wielding Antibody-Drug Conjugates & Companion Diagnostics to Revolutionize Patient Care & Optimize Cancer Treatment
Time: 2:50 pm
day: Day Two Track C
Details:
- Biomarker assays to predict response to antibody-drug conjugates
- Immunohistochemistry assay development for impactful ADC companion diagnostics
- Clinical utilization of companion diagnostics to tailor treatment for improved patient outcomes
